| Literature DB >> 29311718 |
Shengru Wu1, Wei Guo1, Saisai Liang1, Hong Lu1, Wenqiang Sun1, Xiaochun Ren1,2, Qingzhu Sun1, Xiaojun Yang3.
Abstract
The liver function of chickens is intensively remodeled from birth to adult, which was validated by metabolomics research in the present study. In order to understand the roles of microRNAs (miRNA) in liver maturation and metergasis, miRNA expression profiles in livers of 20 male chicks aged one day and five adult cocks aged 35 weeks were determined. A total of 191 differentially expressed miRNAs with the criteria of P < 0.05 and fold changes either >1.5 or <0.67 and 32 differentially expressed miRNAs with the criteria of false discovery value (FDR) < 0.05 and fold changes either >1.5 or <0.67 were detected. Subsequently, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses of the targets revealed that candidate miRNAs may involve in the regulation of hepatic metabolism and immune functions, and some pathways including cell cycle which were implicated in postnatal liver development. Furthermore, 1211 differentially expressed mRNAs (messenger RNA) in livers between the postnatal and matured chickens were used to define the roles of differentially expressed miRNAs in regulating the expression of target genes. Our results revealed the first miRNA profile related to the adaption of mature liver functions after birth in breeder cock.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29311718 PMCID: PMC5758705 DOI: 10.1038/s41598-017-18674-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The heat map of differential metabolites in livers between the postnatal young chicks (YC) and adult chickens (AC). Notes: The up-regulated metabolites are depicted in red color whereas the down-regulated metabolites are depicted in green color.
The significantly enriched pathway of differential metabolites with P < 0.05.
| Pathway | Total | Hits | P value | =−LOG(p) | Impact |
|---|---|---|---|---|---|
| Pentose phosphate pathway | 20 | 7 | <0.000 | 9.8799 | 0.48901 |
| Aminoacyl-tRNA biosynthesis | 44 | 10 | <0.000 | 9.4682 | 0 |
| Valine, leucine and isoleucine biosynthesis | 10 | 5 | <0.000 | 9.3031 | 0 |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 4 | 3 | <0.000 | 7.3815 | 1 |
| Alanine, aspartate and glutamate metabolism | 23 | 6 | 0.001 | 6.8106 | 0.34333 |
| Butanoate metabolism | 18 | 5 | 0.002 | 6.1264 | 0 |
| Phenylalanine metabolism | 8 | 3 | 0.007 | 4.904 | 0.58975 |
| Glutathione metabolism | 26 | 5 | 0.012 | 4.4353 | 0.04452 |
| Steroid biosynthesis | 28 | 5 | 0.016 | 4.1202 | 0.34782 |
| Citrate cycle (TCA cycle) | 20 | 4 | 0.021 | 3.8552 | 0.16093 |
| D-Glutamine and D-glutamate metabolism | 5 | 2 | 0.027 | 3.6113 | 1 |
| Taurine and hypotaurine metabolism | 6 | 2 | 0.039 | 3.2419 | 0.5 |
| Glycolysis or Gluconeogenesis | 26 | 4 | 0.050 | 2.9783 | 0.17596 |
Note: (1) the Total is the total number of compounds in the pathway; (2) the Hits is the actually matched number from the uploaded data; (3) the Impact is the pathway impact value calculated from pathway topology analysis.
Figure 2The heat map of differentially expressed miRNAs for livers between the postnatal chicks (YC) and adult chickens (AC). Notes: The up-regulated miRNAs are depicted in red color whereas the down-regulated miRNAs are depicted in green color. YC1, YC2, and YC3 represent the results of 3 replications from the postnatal young chicks using RNA sequencing and AC1, AC2, and AC3 represent the results of 3 replications from adult chickens using RNA sequencing.
Summary of differentially expressed miRNAs which selected with the criteria of FDR < 0.05 and fold changes either >1.5 or <0.67 in livers between the postnatal (YC) and matured chickens (AC).
| Name | Sequence | AC1 | AC2 | AC3 | YC1 | YC2 | YC3 | Fold Changes (AC/YC) | FDR value |
|---|---|---|---|---|---|---|---|---|---|
| gga-miR-125b-5p | TCCCTGAGACCCTAACTTGTGA | 58677.75 | 55626.50 | 56667.41 | 32650.48 | 26424.53 | 23446.84 | 2.07 | 0.03 |
| aca-miR-191-5p_R-1 | CAACGGAATCCCAAAAGCAGCT | 57152.94 | 75715.60 | 64057.34 | 16422.00 | 14792.69 | 11220.11 | 4.64 | 0.04 |
| gga-miR-107-3p_R-1 | AGCAGCATTGTACAGGGCTATC | 6369.26 | 7804.42 | 7933.42 | 17972.62 | 16911.23 | 17611.13 | 0.42 | 0.02 |
| gga-let-7b_R + 2 | TGAGGTAGTAGGTTGTGTGGTTTT | 2391.77 | 2699.59 | 2956.35 | 504.96 | 423.82 | 342.41 | 6.33 | 0.02 |
| aca-miR-363-3p_R + 1 | AATTGCACGGTATCCATCTGTA | 2108.82 | 3097.80 | 2316.88 | 10026.60 | 9279.55 | 9535.19 | 0.26 | 0.02 |
| oan-miR-363-3p_R + 1 | AATTGCACGGTATCCATCTGTA | 2108.82 | 3097.80 | 2316.88 | 10026.60 | 9279.55 | 9535.19 | 0.26 | 0.02 |
| gga-miR-181b-5p_R + 1 | AACATTCATTGCTGTCGGTGGGT | 1989.16 | 1916.79 | 2396.51 | 5621.88 | 5157.39 | 4870.29 | 0.40 | 0.03 |
| gga-miR-20b-5p | CAAAGTGCTCATAGTGCAGGTAG | 1832.73 | 2452.51 | 2603.00 | 8999.41 | 10104.73 | 9234.32 | 0.24 | 0.02 |
| gga-miR-458a-3p | ATAGCTCTTTGAATGGTACTGC | 1085.15 | 1143.90 | 984.38 | 211.99 | 166.56 | 198.19 | 5.57 | 0.02 |
| gga-miR-456-3p_1ss22AT | CAGGCTGGTTAGATGGTTGTCT | 857.08 | 899.48 | 633.92 | 2657.60 | 2921.09 | 3110.16 | 0.28 | 0.02 |
| gga-miR-1729-5p_R-1 | ATCCCTTACTCACATGAGTAGT | 706.42 | 675.66 | 753.52 | 278.68 | 361.75 | 353.20 | 2.15 | 0.03 |
| rno-miR-122-5p_L + 1 R + 1_2 | CTGGAGTGTGACAATGGTGTTTGT | 582.92 | 585.29 | 541.57 | 312.62 | 363.88 | 361.05 | 1.65 | 0.03 |
| rno-miR-122-5p_L + 1 R + 1_1 | CTGGAGTGTGACAATGGTGTTTGA | 582.92 | 585.29 | 541.57 | 312.62 | 363.88 | 361.05 | 1.65 | 0.03 |
| gga-miR-146a-3p_R-1 | ACCCATGGGGCTCAGTTCTTCA | 469.30 | 520.09 | 579.09 | 161.97 | 138.97 | 125.58 | 3.68 | 0.03 |
| mmu-let-7j_1ss8TG | TGAGGTAGTAGTTTGTGCTGTTAT | 450.36 | 394.26 | 459.49 | 145.89 | 143.22 | 63.77 | 3.70 | 0.04 |
| gga-miR-1451-3p_R-1 | CGTAACTCGCTGCTGTGAGAGG | 97.15 | 94.56 | 85.29 | 169.11 | 188.83 | 186.41 | 0.51 | 0.03 |
| gga-miR-456-3p_R-1 | CAGGCTGGTTAGATGGTTGTC | 55.16 | 58.34 | 37.52 | 167.33 | 159.66 | 166.79 | 0.31 | 0.02 |
| gga-miR-106-3p_R + 1 | ACTGCAGTATAAGCACTTCTGGC | 54.34 | 57.19 | 63.81 | 307.26 | 285.90 | 288.45 | 0.20 | 0.00 |
| gga-miR-130b-5p_R-1 | CCTCTTTCCCTGTTGCACTAC | 46.93 | 57.96 | 39.12 | 176.26 | 141.63 | 164.83 | 0.30 | 0.04 |
| gga-miR-301a-5p_L + 2 | GCTCTGACAATGTTGCACTACT | 26.35 | 44.23 | 33.99 | 226.28 | 214.29 | 233.51 | 0.16 | 0.02 |
| cin-miR-33_R + 4 | GTGCATTGTAGTTGCATTGCAAT | 23.05 | 22.12 | 22.45 | 0.00 | 3.18 | 3.92 | 9.52 | 0.02 |
| aca-miR-18a-3p_L + 1R-1_1ss12GA | TACTGCCCTAAATGCTCCTTCT | 21.41 | 28.22 | 20.52 | 86.94 | 107.15 | 98.11 | 0.24 | 0.03 |
| gga-miR-1559-3p | AGTTACATGTATGCATCGAGCA | 11.53 | 8.39 | 10.90 | 25.01 | 27.58 | 29.43 | 0.38 | 0.03 |
| gga-miR-128-1-5p | CGGGGCCGTAACACTGTCTGAGA | 8.23 | 12.96 | 13.47 | 38.11 | 42.43 | 39.24 | 0.29 | 0.02 |
| aca-miR-363-5p | GTGGATCACGATGCAATTTTGA | 4.94 | 2.54 | 3.95 | 25.21 | 27.94 | 34.34 | 0.13 | 0.04 |
| pma-miR-456_R + 1_1ss22AC | CAGGCTGGTTAGATGGTTGTCCC | 4.94 | 2.29 | 3.85 | 13.10 | 13.79 | 13.74 | 0.27 | 0.03 |
| gga-let-7j-3p_L-1R + 2 | TATACAGTCTATTGCCTTCCTTT | 3.17 | 2.94 | 3.00 | 0.95 | 0.34 | 0.25 | 5.92 | 0.03 |
| gga-miR-3529 | AGGCAGACTGTGACTTGTTGT | 1.65 | 4.58 | 3.85 | 16.08 | 14.85 | 13.74 | 0.23 | 0.03 |
| PC-3p-68190_58 | CTGATGAGGATCTTAAAA | 1.65 | 0.00 | 0.00 | 13.10 | 10.61 | 13.74 | 0.04 | 0.03 |
| gga-miR-202-5p_L-1 | TTCCTATGCATATACTTCTTT | 0.00 | 0.76 | 1.28 | 7.15 | 6.37 | 5.89 | 0.11 | 0.03 |
| gga-miR-489-3p_L-2R + 1 | TGACATCATATGTACGGCTGCT | 0.00 | 0.76 | 0.00 | 9.53 | 8.49 | 7.85 | 0.03 | 0.02 |
| gga-miR-6710-3p_R + 1 | AAACTGTTCTCTTCCATCTAGT | 0.00 | 0.38 | 1.28 | 4.76 | 4.24 | 4.91 | 0.12 | 0.04 |
Figure 3Eight differentially expressed miRNAs, which were validated by reverse-transcription quantitative polymerase chain reaction. Notes: 1. AC represent the livers of adult chickens, YC represent the livers of the postnatal young chickens; 2. Superscripts (a,b) on bars denote significantly different expression levels in the same miRNAs (P < 0.05). 3. U6 (a), 5 S (b), 18 S (c) were respectively used as internal control gene for normalization in our experiments. The data are all presented as means ± SE (for postnatal chicks: n = 20; for adult chickens: n = 5).
Figure 4The miRNAs-genes network of cell cycle pathway (ko04110). Note: 1. (a) the miRNAs-genes network of cell cycle pathway (ko04110) constructed based on differentially expressed miRNAs (screened out with the criteria of P < 0.05 and fold changes either >1.5 or <0.67) and their targets; (b) the miRNAs-genes network of cell cycle pathway (ko04110) constructed based on differentially expressed miRNAs (screened out with the criteria of FDR < 0.05 and fold changes either >1.5 or <0.67) and their targets. 2. White circular nodes represent potential target genes which were involved in the cell cycle pathway, and red rectangular and pink rounded rectangle nodes represent identified differentially expressed miRNAs which were involved in the cell cycle pathway. The size of the nodes represents the power of the interrelation among the nodes, and edges between two nodes represent interactions between genes. The more edges a gene has, the more miRNAs that interact with it, and the more central a role it had within the network.
Figure 5MiR-122–5p mimic or negative control (miR-NTC) and luciferase reporter genes with TGFβ3 or RAD21 3′UTRs in psiCHECKTM-2 vectors were co-transfected into HEK293T cells. Note: (a) The overexpression of miR-122–5p was detected at 48 h in miR-122-5p group after transfection. (b) Renilla luciferase activity was normalized to firefly luciferase. All measurements shown are the means ± SE (n = 4). Superscripts (a,b) denote significantly different expression levels in the same microRNAs (P < 0.05).
Differentially expressed miRNAs and their transcriptional dependent target mRNAs which were associated with the postnatal hepatic metabolic functional changes.
| Item | Metabolic Pathway | Differentially expressed metabolites | Related pathway based on differentially expressed miRNAs | Differentially expressed miRNAs1 | Intersection targets mRNAs |
|---|---|---|---|---|---|
| glycometabolism | Citrate cycle (TCA cycle) | fumaric acid, 2-ketoglutaric acid, succinic acid, malic acid, pyruvic acid | Citrate cycle (TCA cycle) or Pyruvate metabolism | gga-let-7b_L-1R-1/ola-miR-126-5p_R + 1_1ss1CN | ALDH3A2 |
| gga-let-7c-3p_1ss12TC/gga-miR-106-3p_R + 1(FDR < 0.05)/gga-miR-130b-3p/gga-miR-1467-3p_L + 1/gga-miR-17-3p_L-1R + 3/gga-miR-20b-5p (FDR < 0.05)/gga-miR-454-3p | LDHA | ||||
| hsa-miR-3120-3p_R + 1 | PDHA1 | ||||
| gga-miR-1329-5p/gga-miR-9-5p/rno-miR-122-5p_L + 1 R + 1_1 (FDR < 0.05)/rno-miR-122-5p_L + 1 R + 1_2 (FDR < 0.05) | SUCLG1 | ||||
| aca-miR-363-3p_R + 1 | ACO2 | ||||
| Glycolysis/Gluconeogenesis | pyruvic acid, 2-phosphoglyceric acid, 3-phosphoglyceric acid, glucose 6-phosphate, fructose 6-phosphate, dihydroxyacetone phosphate | Glycolysis/Gluconeogenesis | gga-let-7b_L-1R-1/ola-miR-126-5p_R + 1_1ss1CN | ALDH3A2 | |
| cin-miR-33_R + 4 (FDR < 0.05)/gga-miR-214_L + 1R-3_1ss19GA/gga-miR-22-3p/gga-miR-29b-3p_R-1/gga-miR-29c-3p_R + 1/gga-miR-29c-3p_R + 1_1ss18GA/gga-miR-33-5p/hsa-miR-3120-3p_R + 1/ola-miR-199a-3p_R + 1_1ss22AG/ssa-miR-29b-3p_R-1_2ss20TC21TC | BPGM | ||||
| gga-let-7c-3p_1ss12TC/gga-miR-106-3p_R + 1 (FDR < 0.05)/gga-miR-130b-3p/gga-miR-1467-3p_L + 1/gga-miR-17-3p_L-1R + 3/gga-miR-20b-5p (FDR < 0.05)/gga-miR-454-3p | LDHA | ||||
| hsa-miR-3120-3p_R + 1 | PDHA1 | ||||
| gga-mir-147-p3_2 | PFKL | ||||
| gga-miR-22-3p | TPI1 | ||||
| amino acid or protein metabolism | Valine, leucine and isoleucine biosynthesis/degradation | Isoleucine, leucine, valine, 2-ketoisocaproic acid | Valine, leucine and isoleucine degradation | aca-miR-18a-3p_L + 1R-1_1ss12GA (FDR < 0.05)/csa-let-7d_1ss10TC/gga-miR-130b-3p/gga-miR-1699_L-1R-2/gga-miR-1788-3p_R + 1/gga-miR-1788-5p/gga-miR-216b/gga-miR-301a-5p_L + 2 (FDR < 0.05)/gga-miR-3529 (FDR < 0.05)/gga-miR-383-3p/gga-miR-454-3p/gga-miR-460a-5p/gga-miR-6548-5p/mmu-mir-5098-p5/oha-miR-7-1-3p_1ss10GA | ACADSB |
| gga-let-7b_L-1R-1/ola-miR-126-5p_R + 1_1ss1CN | ALDH3A2 | ||||
| gga-miR-142-5p_L-2R + 1/mmu-miR-3964_L + 1_1ss6GA | HIBADH | ||||
| gga-miR-1731-5p/gga-miR-1759-3p_L-3/gga-miR-1788-3p_R + 1/gga-miR-6548-5p | HMGCL | ||||
| Arginine and proline metabolism | 4-hydroxyproline, 5-aminopentanoic acid, putrescine, ornithine, glutamic acid, sarcosine | Arginine and proline metabolism | gga-let-7b_L-1R-1/ola-miR-126-5p_R + 1_1ss1CN | ALDH3A2 | |
| ola-miR-199a-3p_R + 1_1ss22AG | ALDH4A1 | ||||
| gga-let-7a-5p/gga-let-7a-5p_2ss12GT18TC/gga-let-7b_R + 2(FDR < 0.05)/gga-let-7c-5p_1ss17AG/gga-let-7g-5p_R + 1_2ss14TG18CA/gga-let-7k-5p_R + 1_1ss16AT/gga-miR-22-3p/mmu-let-7j_1ss8TG (FDR < 0.05) | GATM | ||||
| gga-miR-20b-3p_R-1 | GLS | ||||
| dre-miR-24_R + 2/gga-miR-9-5p | GOT1 | ||||
| gga-miR-1747-3p/gga-miR-1796/gga-miR-20b-3p_R-1 | P4HA1 | ||||
| aca-miR-425-5p_R + 4/dre-miR-24_R + 2/gga-miR-200b-5p_L + 2/gga-miR-223_1ss15AG/gga-miR-223_1ss19CT/gga-miR-223_R + 1/hsa-miR-425-5p_R + 2_1ss20TC | SRM | ||||
| Glutathione metabolism | Putrescine, dehydroascorbic acid, cadaverine | Glutathione metabolism | gga-miR-17-3p_L-1R + 3/gga-miR-20b-3p_R-1/gga-miR-34a-3p_R-1/gga-miR-6604-5p_1ss7GA/mmu-miR-8094_L + 1 R + 3_1ss3AG | GSTA | |
| gga-miR-489-3p_L-2R + 1 (FDR < 0.05) | GSTO1 | ||||
| gga-let-7f-3p_1ss22CT/gga-miR-1329-5p/hsa-miR-3120-3p_R + 1 | RRM1 | ||||
| aca-miR-425-5p_R + 4/dre-miR-24_R + 2/gga-miR-200b-5p_L + 2/gga-miR-223_1ss15AG/gga-miR-223_1ss19CT/gga-miR-223_R + 1/hsa-miR-425-5p_R + 2_1ss20TC | SRM | ||||
| Taurine and hypotaurine metabolism/Cysteine and methionine metabolism | Taurine, 2-aminobutyric acid, methionine, cysteine | Cysteine and methionine metabolism | gga-miR-214_L + 1R-3_1ss19GA | CTH | |
| dre-miR-24_R + 2/gga-miR-9-5p | GOT1 | ||||
| gga-let-7c-3p_1ss12TC/gga-miR-106-3p_R + 1 (FDR < 0.05)/gga-miR-130b-3p/gga-miR-1467-3p_L + 1/gga-miR-17-3p_L-1R + 3/gga-miR-20b-5p (FDR < 0.05)/gga-miR-454-3p | LDHA | ||||
| aca-miR-425-5p_R + 4/dre-miR-24_R + 2/gga-miR-200b-5p_L + 2/gga-miR-223_1ss15AG/gga-miR-223_1ss19CT/gga-miR-223_R + 1/hsa-miR-425-5p_R + 2_1ss20TC | SRM | ||||
| aca-miR-18a-3p_L + 1R-1_1ss12GA (FDR < 0.05)/gga-miR-107-5p_R + 1/gga-miR-342_R + 1 | TAT | ||||
| Lipid metabolism | Steroid biosynthesis | Lanosterin, 4α-methylzymosterol, campesterol, desmosterol, dihydrocholesterol, stigmasterol, cholesterol | PPAR signaling pathway | aca-miR-363-3p_R + 1 (FDR < 0.05)/gga-miR-106-3p_R + 1 (FDR < 0.05)/gga-miR-1783_R + 1/gga-miR-181b-5p_R + 1 (FDR < 0.05)/gga-miR-205a_R + 1/gga-miR-205b/gga-miR-460a-5p/ggo-miR-342_R + 1/oan-miR-363-3p_R + 1 (FDR < 0.05)/tni-miR-205_R + 2 | ACSBG2 |
| gga-miR-1662_R-3/tgu-miR-1662_L + 1_1ss23TA | CYP7A1 | ||||
| gga-miR-1716_L-2 | FABP3 | ||||
| gga-miR-1559-3p (FDR < 0.05)/gga-miR-16-1-3p_R-1/gga-miR-20b-5p (FDR < 0.05)/gga-miR-456-3p_1ss22AT (FDR < 0.05)/gga-miR-456-3p_R-1 (FDR < 0.05)/oan-miR-363-3p_R + 1 (FDR < 0.05)/pma-miR-456_R + 1_1ss22AC (FDR < 0.05)/aca-miR-363-5p(FDR < 0.05) | FABP5 | ||||
| hsa-miR-3120-3p_R + 1/oan-let-7f-1-3p_R + 2_1ss8AG | FABP7 | ||||
| cgr-miR-151-3p/gga-miR-1467-3p_L + 1 | FADS2 | ||||
| gga-miR-2954_R + 2/gga-miR-458a-3p(FDR < 0.05) | LPL | ||||
| Fatty acid metabolism | arachidonic acid, docosahexaenoic acid, margaric acid, oleic acid, stearic acid, tetradecanoic acid, cis-9-hexadecenoic acid | Fatty acid metabolism | aca-miR-18a-3p_L + 1R-1_1ss12GA (FDR < 0.05)/csa-let-7d_1ss10TC/gga-miR-130b-3p /gga-miR-1699_L-1R-2/gga-miR-1788-3p_R + 1/gga-miR-1788-5p/gga-miR-216b/gga-miR-301a-5p_L + 2 (FDR < 0.05)/gga-miR-3529 (FDR < 0.05)/gga-miR-383-3p/gga-miR-454-3p/gga-miR-460a-5p/gga-miR-6548-5p/mmu-mir-5098-p5/oha-miR-7-1-3p_1ss10GA | ACADSB | |
| gga-miR-106-3p_R + 1(FDR < 0.05)/gga-miR-1783_R + 1/gga-miR-181b-5p_R + 1(FDR < 0.05)/gga-miR-205a_R + 1/gga-miR-205b/gga-miR-460a-5p/gga-miR-342_R + 1/oan-miR-363-3p_R + 1(FDR < 0.05)/tni-miR-205_R + 2/aca-miR-363-3p_R + 1(FDR < 0.05) | ACSBG2 | ||||
| gga-let-7b_L-1R-1/ola-miR-126-5p_R + 1_1ss1CN | ALDH3A2 |
Note: 1The FDR < 0.05 followed by those differentially expressed miRNAs represented that those miRNAs were selected based on the criteria of FDR < 0.05 and fold changes either >1.5 or <0.67; other differentially miRNAs without the following label of FDR <0.05 were selected based on the criteria of P < 0.05 and fold changes either >1.5 or <0.67.